## Abstract Clozapine has been demonstrated to bind covalently to proteins as a result of metabolic activation that has been proposed to be a precursor to the serious side effects including death that occur in a small percentage of the population. The covalent modification of proteins by clozapine
Synthesis of 14C-labelled 10-[3-(dimethylamino)-propyl]-2-nitrodibenz [b,f] [1,4] oxazepin-11-(10 H)-one (nitroxazepine)hydrochloride
β Scribed by R. K. Maller; K. Nagarajan
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- French
- Weight
- 321 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
For pharmacokinetic and metabolism s t u d i e s i n a n i m a l s and humans, n i t r o x a z e p i n e , an a n t i d e p r e s s a n t , was l a b e l l e d w i t h carbon-14 a t t h e 1 1 -p o s i t i o n of t h e dibenzoxazepine r i n g system i n an o v e r a l l y i e l d of 12A s t a r t i n g w i t h potassium [I4C] cyanide. The l a b e l l e d p r e p a r a t i o n had a s p e c i f i c a c t i v i t y of 0.95 yCi/mg.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
## Abstract The synthesis of the Cβ14 labeled isotopomer of LY300502, a potent 5Ξ±βreductase inhibitor has been accomplished in four radiochemical steps. The route involves the synthesis of LY300502β[^14^C] from LY300502 __via__ a circuitous route; the label was introduced with ethyl chloroformateβ[